SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001387131-20-002365
Filing Date
2020-02-28
Accepted
2020-02-28 17:23:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b5_022820.htm 424B5 580969
2 GRAPHIC tnxp424b5022820001.jpg GRAPHIC 14725
3 GRAPHIC img001_v1.jpg GRAPHIC 11393
  Complete submission text file 0001387131-20-002365.txt   618301
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
Type: 424B5 | Act: 33 | File No.: 333-224586 | Film No.: 20672453
SIC: 2834 Pharmaceutical Preparations